Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM. by Masami Kishi (6167105)

“…The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”

Foxa1 decreases FA uptake. by Marta Moya (188959)

SAA decreases the expression of adipocyte markers. by Aurélie Faty (169741)

Germ cell size decreases before corpse formation. by Tea Kohlbrenner (19476160)

At lower concentrations, METH decreases LTP. by Jarod Swant (246454)

“…At 0.1 µM METH, LTP was 1.58±.08 [<i>n</i> = 13(5)] (Fig. 1B); at 1 µM METH, LTP was 1.50±.07 [<i>n</i> = 13(7)] (Fig. 1C); at 10 µM METH, LTP was 1.58±.07 [<i>n</i> = 14(8)] (Fig. 1D); at 30 µM METH, LTP was 1.37±.06 [<i>n</i> = 15(4)] (Fig. 1E); and at 60 µM METH, LTP was 1.32±.24 [<i>n</i> = 4(2)] (Fig. 1E). …”

Absence of adaptive immunity decreases tumor cell damage in MDR1A deficiency. by Eva Maria Hennenberg (4234018)

Jasplakinolide decreased late EPC proliferation. by Xiaoyun Zhang (115529)

A low dose of BTZ decreases proteasome activity with no effect on cell viability. by A. L. Furfaro (2587792)

LMP1 decreases mitochondrial respiration. by Michael Hulse (5932112)

Promoter activities of DNA-DRR genes decreased with DEC. by Hideaki Nakamura (402108)

CK2α decreases CLK transcription factor activity. by Áron Szabó (450885)

2-ME decreases blood pressure in Sprague Dawley rats. by Weiyu Chen (2216251)

Decreased natTregs observed in the lungs in the absence of TLR2. by Amanda McBride (421742)

The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

“…(<b>C</b>) Isoginkgetin treatment leads to a decreased rate of lariat formation (* indicates <i>p</i> = 0.02) without affecting exon ligation or excised lariat degradation (<i>p</i> = 0.22, 0.08), with calculations as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone-0089673-g001" target="_blank">Fig. 1</a>. …”

Grb2 silencing decreases phagocytic uptake in RPE cells. by Shameka J. Shelby (279119)

Overexpression of Pax6 decreases Olig2 protein levels. by Eun Sook Jang (217069)

“…(<b>a</b>) Oli-Neu cells were transfected with flag-tagged WT Pax6 (WT), Pax6(5a)R128C (128), or eGFP control vector (-). …”

AICAR-activated AMPK decreased SREBP-2 protein levels. by Shudong Liu (733425)

The expression of genes related to mitochondria was decreased in Pgam2 mice. by Junji Okuda (444322)

“…Peroxisome proliferator-activated receptor α (PPARα), peroxisome proliferator-activated receptor δ (PPARδ), estrogen related receptor α (ERRα), mitochondrial transcription factor A (Tfam), carnitine palmitoyltransferase 1b (CPT-1b), isocitrate dehydrogenase 3 α (IDH3α), oxoglutarate dehydrogenase (OgDh), succinyl-CoA synthetase α (SCS), mitochondrially encoded NADH dehydrogenase 4 (ND4), alpha-subcomplex 9 of complex I (α-s9), mitochondrial succinate dehydrogenase iron-sulfur subunit (SDHB), iron-sulfur protein (Fe-S), cytochrome b (Cyt-b), cytochrome c (Cyt-c), cytochrome c oxidase subunit VIIa (COX7a), uncoupling protein 2 (UCP2), uncoupling protein 3 (UCP3), and manganese superoxide dismutase (Mn-SOD) levels were decreased in Pgam2 mice. …”

Vasopressin decreases EPSPs in CA2 after LTP induction. by Magda Chafai (295116)

“…<p>A: Top: typical recordings of the combined EPSP/IPSP evoked by stimulation of LIII entorhinal fibers (EC LIII) and recorded in CA2 pyramidal neurons (inset). …”

Treating obesity decreases TNF-α levels in the obesity-related asthma model. by Joo Young Kim (128707)